Guillaume Cerutti - Net Worth and Insider Trading

Guillaume Cerutti Net Worth

The estimated net worth of Guillaume Cerutti is at least $281,749 dollars as of 2024-11-13. Guillaume Cerutti is the Director of Avadel Pharmaceuticals PLC and owns about 23,440 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $281,749. Details can be seen in Guillaume Cerutti's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Guillaume Cerutti has not made any transactions after 2017-06-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Guillaume Cerutti

To

Guillaume Cerutti Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Guillaume Cerutti owns 1 companies in total, including Avadel Pharmaceuticals PLC (AVDL) .

Click here to see the complete history of Guillaume Cerutti’s form 4 insider trades.

Insider Ownership Summary of Guillaume Cerutti

Ticker Comapny Transaction Date Type of Owner
AVDL Avadel Pharmaceuticals PLC 2017-06-15 director

Guillaume Cerutti Latest Holdings Summary

Guillaume Cerutti currently owns a total of 1 stock. Guillaume Cerutti owns 23,440 shares of Avadel Pharmaceuticals PLC (AVDL) as of June 15, 2017, with a value of $281,749.

Latest Holdings of Guillaume Cerutti

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AVDL Avadel Pharmaceuticals PLC 2017-06-15 23,440 12.02 281,749

Holding Weightings of Guillaume Cerutti


Guillaume Cerutti Form 4 Trading Tracker

According to the SEC Form 4 filings, Guillaume Cerutti has made a total of 0 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years. The most-recent trade in Avadel Pharmaceuticals PLC is the sale of 26,560 shares on June 15, 2017, which brought Guillaume Cerutti around $277,818.

Insider Trading History of Guillaume Cerutti

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Guillaume Cerutti Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Guillaume Cerutti Ownership Network

Ownership Network List of Guillaume Cerutti

No Data

Ownership Network Relation of Guillaume Cerutti

Insider Network Chart

Guillaume Cerutti Owned Company Details

What does Avadel Pharmaceuticals PLC do?

Who are the key executives at Avadel Pharmaceuticals PLC?

Guillaume Cerutti is the director of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .

Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary

Over the past 18 months, Guillaume Cerutti made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 41,000 shares were bought by its insiders, resulting in a net sale of 62,975 shares.

Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avadel Pharmaceuticals PLC Insider Transactions

No Available Data

Guillaume Cerutti Mailing Address

Above is the net worth, insider trading, and ownership report for Guillaume Cerutti. You might contact Guillaume Cerutti via mailing address: Block 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin L2 15.